Dopamine receptors: a review.
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D003400:Astacoidea; D001665:Binding Sites; D001921:Brain / Q000187:drug effects; D002395:Catecholamines / Q000037:antagonists & inhibitors / Q000494:pharmacology; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects; D002746:Chlorpromazine / Q000494:pharmacology; D003864:Depression, Chemical; D004285:Dogs; D004298:Dopamine / Q000494:pharmacology*; D018492:Dopamine Antagonists; D006220:Haloperidol / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D007668:Kidney / Q000187:drug effects; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D008954:Models, Biological; D009433:Neural Inhibition; D009474:Neurons / Q000187:drug effects; D011817:Rabbits; D011955:Receptors, Drug; D012701:Serotonin / Q000494:pharmacology; D012908:Snails; D013329:Structure-Activity Relationship; D013566:Sympathomimetics / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology
D000316:Adrenergic alpha-Agonists; D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D018492:Dopamine Antagonists; D011955:Receptors, Drug; D013566:Sympathomimetics; D014665:Vasodilator Agents; D012701:Serotonin; D008238:Lysergic Acid Diethylamide; D006220:Haloperidol; D007545:Isoproterenol; D002746:Chlorpromazine; D004298:Dopamine